COVID-19 telehealth preparedness: a cross-sectional assessment of cardiology practices in the USA.

IF 1.7 4区医学 Q3 PHARMACOLOGY & PHARMACY

Personalized medicine Pub Date : 2022-09-01 Epub Date: 2022-08-01 DOI:10.2217/pme-2021-0179

Carly E Waldman, Jean H Min, Heba Wassif, Andrew M Freeman, Anne K Rzeszut, Jack Reilly, Paul Theriot, Ahmed M Soliman, Ritu Thamman, Ami Bhatt, Sanjeev P Bhavnani

{"title":"COVID-19 telehealth preparedness: a cross-sectional assessment of cardiology practices in the USA.","authors":"Carly E Waldman, Jean H Min, Heba Wassif, Andrew M Freeman, Anne K Rzeszut, Jack Reilly, Paul Theriot, Ahmed M Soliman, Ritu Thamman, Ami Bhatt, Sanjeev P Bhavnani","doi":"10.2217/pme-2021-0179","DOIUrl":null,"url":null,"abstract":"Aim: The COVID-19 pandemic forced medical practices to augment healthcare delivery to remote and virtual services. We describe the results of a nationwide survey of cardiovascular professionals regarding telehealth perspectives. Materials & methods: A 31-question survey was sent early in the pandemic to assess the impact of COVID-19 on telehealth adoption & reimbursement. Results: A total of 342 clinicians across 42 states participated. 77% were using telehealth, with the majority initiating usage 2 months after the COVID-19 shutdown. A variety of video-based systems were used. Telehealth integration requirements differed, with electronic medical record integration being mandated in more urban than rural practices (70 vs 59%; p < 0.005). Many implementation barriers surfaced, with over 75% of respondents emphasizing reimbursement uncertainty and concerns for telehealth generalizability given the complexity of cardiovascular diseases. Conclusion: Substantial variation exists in telehealth practices. Further studies and legislation are needed to improve access, reimbursement and the quality of telehealth-based cardiovascular care.","PeriodicalId":19753,"journal":{"name":"Personalized medicine","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Personalized medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/pme-2021-0179","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/8/1 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}

引用次数: 1

Abstract

Aim: The COVID-19 pandemic forced medical practices to augment healthcare delivery to remote and virtual services. We describe the results of a nationwide survey of cardiovascular professionals regarding telehealth perspectives. Materials & methods: A 31-question survey was sent early in the pandemic to assess the impact of COVID-19 on telehealth adoption & reimbursement. Results: A total of 342 clinicians across 42 states participated. 77% were using telehealth, with the majority initiating usage 2 months after the COVID-19 shutdown. A variety of video-based systems were used. Telehealth integration requirements differed, with electronic medical record integration being mandated in more urban than rural practices (70 vs 59%; p < 0.005). Many implementation barriers surfaced, with over 75% of respondents emphasizing reimbursement uncertainty and concerns for telehealth generalizability given the complexity of cardiovascular diseases. Conclusion: Substantial variation exists in telehealth practices. Further studies and legislation are needed to improve access, reimbursement and the quality of telehealth-based cardiovascular care.

查看原文本刊更多论文

COVID-19远程医疗准备:美国心脏病学实践的横断面评估

目的:2019冠状病毒病大流行迫使医疗实践将医疗保健服务扩大到远程和虚拟服务。我们描述了一项关于远程医疗观点的全国性心血管专业人员调查的结果。材料和方法:在大流行早期进行了一项包含31个问题的调查，以评估COVID-19对远程医疗采用和报销的影响。结果:共有来自42个州的342名临床医生参与。77%的人正在使用远程医疗，大多数人在COVID-19关闭后2个月开始使用。使用了各种基于视频的系统。远程医疗一体化要求各不相同，城市要求电子病历一体化的比例高于农村(70% vs 59%;p结论:远程医疗实践存在实质性差异。需要进一步的研究和立法来改善基于远程保健的心血管护理的获取、报销和质量。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Personalized medicine 医学-药学

CiteScore

3.30

自引率

4.30%

发文量

审稿时长

6-12 weeks

期刊介绍： Personalized Medicine (ISSN 1741-0541) translates recent genomic, genetic and proteomic advances into the clinical context. The journal provides an integrated forum for all players involved - academic and clinical researchers, pharmaceutical companies, regulatory authorities, healthcare management organizations, patient organizations and others in the healthcare community. Personalized Medicine assists these parties to shape thefuture of medicine by providing a platform for expert commentary and analysis. The journal addresses scientific, commercial and policy issues in the field of precision medicine and includes news and views, current awareness regarding new biomarkers, concise commentary and analysis, reports from the conference circuit and full review articles.